Press Releases | Health Daily Finland

Mar. 12, 2026

PsyMetRiC – a new tool to predict physical health risks in young people with psychosis

EIN Presswire

Mar. 12, 2026

Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia

GlobeNewswire, Inc.

Mar. 11, 2026

Albanian-Finnish Startup Bliss Raises $270K to Build Culturally Intelligent AI for Therapy

GlobeNewswire, Inc.

Mar. 5, 2026

Herantis Pharma releases 2H and FY 2025 report today

GlobeNewswire, Inc.

Mar. 2, 2026

Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN

GlobeNewswire, Inc.

Mar. 13, 2026

Researchers Break Decades-old Bottleneck in Chemotherapy Drug Manufacturing

EIN Presswire

Feb. 27, 2026

A Guide to Philadelphia’s Top Luxury Wellness & Recovery Spots

Visit Philly - Pennsylvania

Owner: Greater Philadelphia Tourism Marketing Corporation

Visit Philly

Neutral

Owned By	Greater Philadelphia Tourism Marketing Corporation (Non-profit, Angela Val CEO)
Year Founded	1996
Website	https://www.visitphilly.com/
Domain Registration Year	1999
Access Type	open
Publication Location	United States, Pennsylvania, Philadelphia
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Feb. 23, 2026

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

GlobeNewswire, Inc.

Feb. 23, 2026

This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease

GlobeNewswire, Inc.

Feb. 19, 2026

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

GlobeNewswire, Inc.

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 10, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.

Mar. 12, 2026

Rising Demand Driving Hyperspectral Imaging Systems Market to $1.83 Billion by 2030

GlobeNewswire, Inc.

Mar. 4, 2026

Researchers played music to cells – aggressiveness of laryngeal cancer decreased

EIN Presswire

Mar. 11, 2026

Mirasys Welcomes Back Gaming Industry Specialist Ryan Snow to Lead Key Accounts

EIN Presswire

Feb. 26, 2026

Study reveals genetic balancing act between autoimmunity and cancer risk

Broad Institute of MIT and Harvard

Owner: Broad institute (Non-profit)

Broad Institute of MIT and Harvard

Neutral

Owned By	Broad institute (Non-profit, Todd Golub Institute Director, Seth Klarman Chairperson)
Year Founded	2004
Website	www.broadinstitute.org
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	United States, Massachusetts, Cambridge
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Mar. 2, 2026

Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology

GlobeNewswire, Inc.

Feb. 25, 2026

Ellie Launches MCP Server: The First Governed Bridge Between AI and Real Data Models

EIN Presswire